11:13 AM EDT, 10/07/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower Tuesday morning, declining 0.44% to 1,591.64 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which climbed about 12% and 6%, respectively. They were followed by brewing company Anheuser-Busch InBev ( BUD ) and telecommunications company Nokia Oyj ( NOK ) , which increased 1.9% and about 1%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion ( EVAX ) and internet browser company Opera (OPRA), which shed 13% and 4.4%, respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and oil and gas company TotalEnergies (TTE), which lost 1.6% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and Adaptimmune Therapeutics ( ADAP ) , which advanced 11% and 6.9%, respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Amarin ( AMRN ) , which increased 4.9% and 2.9%, respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which fell 4.5% and 3%, respectively. They were followed by cruise operator Carnival (CUK) and lender Lloyds Banking Group ( LYG ) , which were down 1.8% and 1.4%, respectively.